April 29, 2026 — RNews

#safety — Wednesday, April 29, 2026 (1 items)

hot top new

← prev day next day →

0

Immunogenicity and Safety of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine When Co-administered With the Adjuvanted Recombinant Herpes Zoster Subunit Vaccine in Adults >/= 50 Years of Age. (academic.oup.com)

Roussy JF … Van der Wielen M Clinical Infectious Diseases 2026-04-29

#vaccination #clinical trial #immunogenicity #safety #adjuvant